Literature DB >> 25975190

Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

M Tokumasu1, C Murata2, A Shimada3, K Ohki2, Y Hayashi2, A M Saito4, J Fujimoto5, K Horibe4, M Nagao6, H Itoh6, Y Kamikubo6, H Nakayama7, A Kinoshita8, D Tomizawa9, T Taga10, A Tawa11, S Tanaka12, T Heike1, S Adachi6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25975190     DOI： 10.1038/leu.2015.121

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia.

Authors:  Heidi J Nick; Hyung-Gyoon Kim; Chia-Wei Chang; Kevin W Harris; Vishnu Reddy; Christopher A Klug
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.

Authors:  E Manara; V Bisio; R Masetti; V Beqiri; R Rondelli; G Menna; C Micalizzi; N Santoro; F Locatelli; G Basso; M Pigazzi
Journal:  Leukemia       Date:  2013-11-14       Impact factor: 11.528

3.  KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.

Authors:  Akira Shimada; Tomohiko Taki; Ken Tabuchi; Akio Tawa; Keizo Horibe; Masahiro Tsuchida; Ryoji Hanada; Ichiro Tsukimoto; Yasuhide Hayashi
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

4.  High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.

Authors:  M-T Krauth; C Eder; T Alpermann; U Bacher; N Nadarajah; W Kern; C Haferlach; T Haferlach; S Schnittger
Journal:  Leukemia       Date:  2014-01-09       Impact factor: 11.528

5.  Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children.

Authors:  D Tomizawa; A Tawa; T Watanabe; A M Saito; K Kudo; T Taga; S Iwamoto; A Shimada; K Terui; H Moritake; A Kinoshita; H Takahashi; H Nakayama; K Koh; H Kigasawa; Y Kosaka; H Miyachi; K Horibe; T Nakahata; S Adachi
Journal:  Leukemia       Date:  2013-05-16       Impact factor: 11.528

6.  C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.

Authors:  Yue-Ying Wang; Li-Juan Zhao; Chuan-Feng Wu; Ping Liu; Lin Shi; Yang Liang; Shu-Min Xiong; Jian-Qing Mi; Zhu Chen; Ruibao Ren; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

7.  Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.

Authors:  Roberto Cairoli; Alessandro Beghini; Giovanni Grillo; Gianpaolo Nadali; Francesca Elice; Carla Barbara Ripamonti; Patrizia Colapietro; Michele Nichelatti; Laura Pezzetti; Monia Lunghi; Antonio Cuneo; Assunta Viola; Felicetto Ferrara; Mario Lazzarino; Francesco Rodeghiero; Giovanni Pizzolo; Lidia Larizza; Enrica Morra
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

Review 8.  Stem cell factor receptor/c-Kit: from basic science to clinical implications.

Authors:  Johan Lennartsson; Lars Rönnstrand
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

9.  Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.

Authors:  L-Y Shih; D-C Liang; C-F Huang; Y-T Chang; C-L Lai; T-H Lin; C-P Yang; I-J Hung; H-C Liu; T-H Jaing; L-Y Wang; T-C Yeh
Journal:  Leukemia       Date:  2007-10-25       Impact factor: 11.528

10.  Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).

Authors:  Peter Paschka; Juan Du; Richard F Schlenk; Verena I Gaidzik; Lars Bullinger; Andrea Corbacioglu; Daniela Späth; Sabine Kayser; Brigitte Schlegelberger; Jürgen Krauter; Arnold Ganser; Claus-Henning Köhne; Gerhard Held; Marie von Lilienfeld-Toal; Heinz Kirchen; Mathias Rummel; Katharina Götze; Heinz-August Horst; Mark Ringhoffer; Michael Lübbert; Mohammed Wattad; Helmut R Salih; Andrea Kündgen; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2012-10-31       Impact factor: 22.113
View more
  10 in total

1.  Purification of leukemic blast cells from blood smears using laser microdissection.

Authors:  Hidemasa Matsuo; Shuichi Shiga; Tsuyoshi Imai; Yasuhiko Kamikubo; Tsutomu Toki; Kiminori Terui; Etsuro Ito; Souichi Adachi
Journal:  Int J Hematol       Date:  2017-04-13       Impact factor: 2.490

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

3.  Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia.

Authors:  Soheil Meshinchi; Jessica A Pollard; Katherine Tarlock; Todd A Alonzo; Yi-Cheng Wang; Robert B Gerbing; Rhonda Ries; Michael R Loken; Laura Pardo; Tiffany Hylkema; Jason Joaquin; Leela Sarukkai; Susana C Raimondi; Betsy Hirsch; Lillian Sung; Richard Aplenc; Irwin Bernstein; Alan S Gamis
Journal:  Clin Cancer Res       Date:  2019-06-10       Impact factor: 12.531

4.  Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Authors:  Norio Shiba; Kenichi Yoshida; Yusuke Hara; Genki Yamato; Yuichi Shiraishi; Hidemasa Matsuo; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Taeko Kaburagi; Masanobu Takeuchi; Kentaro Ohki; Masashi Sanada; Jun Okubo; Daisuke Tomizawa; Tomohiko Taki; Akira Shimada; Manabu Sotomatsu; Keizo Horibe; Takashi Taga; Souichi Adachi; Akio Tawa; Satoru Miyano; Seishi Ogawa; Yasuhide Hayashi
Journal:  Blood Adv       Date:  2019-10-22

5.  Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.

Authors:  Yachiyo Kuwatsuka; Daisuke Tomizawa; Rika Kihara; Yasunobu Nagata; Norio Shiba; Yuka Iijima-Yamashita; Akira Shimada; Takao Deguchi; Hayato Miyachi; Akio Tawa; Takashi Taga; Akitoshi Kinoshita; Hideki Nakayama; Nobutaka Kiyokawa; Akiko Moriya Saito; Katsuyoshi Koh; Hiroaki Goto; Yoshiyuki Kosaka; Norio Asou; Shigeki Ohtake; Shuichi Miyawaki; Yasushi Miyazaki; Toru Sakura; Yukiyasu Ozawa; Noriko Usui; Heiwa Kanamori; Yoshikazu Ito; Kiyotoshi Imai; Youko Suehiro; Shinichi Kobayashi; Kunio Kitamura; Emiko Sakaida; Seishi Ogawa; Tomoki Naoe; Yasuhide Hayashi; Keizo Horibe; Atsushi Manabe; Shuki Mizutani; Souichi Adachi; Hitoshi Kiyoi
Journal:  Int J Hematol       Date:  2017-10-12       Impact factor: 2.490

6.  Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia.

Authors:  Di Zhan; Yingchi Zhang; Peifang Xiao; Xinchang Zheng; Min Ruan; Jingliao Zhang; Aili Chen; Yao Zou; Yumei Chen; Gang Huang; Shaoyan Hu; Qian-Fei Wang; Xiaofan Zhu
Journal:  Leuk Res       Date:  2017-12-08       Impact factor: 3.715

7.  Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).

Authors:  Celalettin Ustun; Elizabeth Morgan; Erica E M Moodie; Sheeja Pullarkat; Cecilia Yeung; Sigurd Broesby-Olsen; Robert Ohgami; Young Kim; Wolfgang Sperr; Hanne Vestergaard; Dong Chen; Philip M Kluin; Michelle Dolan; Krzysztof Mrózek; David Czuchlewski; Hans-Peter Horny; Tracy I George; Thomas Kielsgaard Kristensen; Nam K Ku; Cecilia Arana Yi; Michael Boe Møller; Guido Marcucci; Linda Baughn; Ana-Iris Schiefer; J R Hilberink; Vinod Pullarkat; Ryan Shanley; Jessica Kohlschmidt; Janie Coulombe; Amandeep Salhotra; Lori Soma; Christina Cho; Michael A Linden; Cem Akin; Jason Gotlib; Gregor Hoermann; Jason Hornick; Ryo Nakamura; Joachim Deeg; Clara D Bloomfield; Daniel Weisdorf; Mark R Litzow; Peter Valent; Gerwin Huls; Miguel-Angel Perales; Gautam Borthakur
Journal:  Cancer Med       Date:  2018-08-16       Impact factor: 4.452

8.  Influence of KIT mutations on prognosis of pediatric patients with core-binding factor acute myeloid leukemia: a systematic review and meta-analysis.

Authors:  Junjie Fan; Li Gao; Jing Chen; Shaoyan Hu
Journal:  Transl Pediatr       Date:  2020-12

9.  Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia.

Authors:  Genki Yamato; Tomoko Kawai; Norio Shiba; Junji Ikeda; Yusuke Hara; Kentaro Ohki; Shin-Ichi Tsujimoto; Taeko Kaburagi; Kenichi Yoshida; Yuichi Shiraishi; Satoru Miyano; Nobutaka Kiyokawa; Daisuke Tomizawa; Akira Shimada; Manabu Sotomatsu; Hirokazu Arakawa; Souichi Adachi; Takashi Taga; Keizo Horibe; Seishi Ogawa; Kenichiro Hata; Yasuhide Hayashi
Journal:  Blood Adv       Date:  2022-06-14

10.  Histiocytic Sarcoma Associated with Coombs Negative Acute Hemolytic Anemia: A Rare Presentation.

Authors:  Sandeep Batra; Stephen C Martin; Mehdi Nassiri; Amna Qureshi; Troy A Markel
Journal:  Case Rep Oncol Med       Date:  2016-06-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.